Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125198462 | 12519846 | 2 | F | 20160718 | 20160630 | 20160727 | EXP | US-PFIZER INC-2016316083 | PFIZER | 71.00 | YR | M | Y | 78.93000 | KG | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125198462 | 12519846 | 1 | PS | RAPAMUNE | SIROLIMUS | 1 | UNK | U | 21110 | TABLET | |||||||||
| 125198462 | 12519846 | 2 | SS | RAPAMUNE | SIROLIMUS | 1 | 3 MG, 1X/DAY( 1MG; 3 TABLETS ONCE PER DAY) | U | 21110 | 3 | MG | TABLET | QD | ||||||
| 125198462 | 12519846 | 3 | C | CYCLOSPORINE. | CYCLOSPORINE | 1 | UNK | 0 | |||||||||||
| 125198462 | 12519846 | 4 | C | TYLENOL WITH CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | 1 DF, AS NEEDED (1 TABLET AS NEEDED) | 0 | 1 | DF | TABLET | ||||||||
| 125198462 | 12519846 | 5 | C | BUMETANIDE. | BUMETANIDE | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
| 125198462 | 12519846 | 6 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 125198462 | 12519846 | 7 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | QD | ||||||||
| 125198462 | 12519846 | 8 | C | ASPIRIN. | ASPIRIN | 1 | 81MG ONE A DAY | 0 | 81 | MG | |||||||||
| 125198462 | 12519846 | 9 | C | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, 2X/DAY | 0 | 300 | MG | BID | ||||||||
| 125198462 | 12519846 | 10 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 2 DF, 1X/DAY (2 TABLETS ONCE DAY) | 0 | 2 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125198462 | 12519846 | 1 | Transplant rejection |
| 125198462 | 12519846 | 3 | Transplant rejection |
| 125198462 | 12519846 | 4 | Pain |
| 125198462 | 12519846 | 5 | Fluid retention |
| 125198462 | 12519846 | 6 | Sleep disorder |
| 125198462 | 12519846 | 7 | Blood pressure abnormal |
| 125198462 | 12519846 | 8 | Coagulopathy |
| 125198462 | 12519846 | 9 | Pain |
| 125198462 | 12519846 | 10 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125198462 | 12519846 | OT |
| 125198462 | 12519846 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125198462 | 12519846 | Dyspnoea | |
| 125198462 | 12519846 | Gait disturbance | |
| 125198462 | 12519846 | Myocardial infarction | |
| 125198462 | 12519846 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125198462 | 12519846 | 1 | 201503 | 0 | ||
| 125198462 | 12519846 | 2 | 201506 | 0 | ||
| 125198462 | 12519846 | 3 | 20020504 | 0 |